Irland - engelska - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder and solvent for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Irland - engelska - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium botulinum type c toxoid; clostridium botulinum type d toxoid; thiomersal - parenteral liquid/solution/suspension - clostridium botulinum type c toxoid vaccine-toxoid active 0.0 p; clostridium botulinum type d toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - botulism

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - botulinum antitoxin type a; botulinum antitoxin type b; botulinum antitoxin type c; botulinum antitoxin type d; botulinum antitoxin type e; botulinum antitoxin type f; botulinum antitoxin type g - powder for solution for injection - 897unit ; 3525unit ; 1545unit ; 495unit ; 1635unit ; 1560unit ; 481unit

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium botulinum type c toxoid; clostridium botulinum type d toxoid; thiomersal - misc. vaccines or anti sera - clostridium botulinum type c toxoid vaccine-toxoid active 5.0 iu/ml; clostridium botulinum type d toxoid vaccine-toxoid active 1.0 iu/ml; thiomersal mercury other 0.13 g/l - immunotherapy - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - botulism

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium botulinum type c toxoid; clostridium botulinum type d toxoid; thiomersal - parenteral liquid/solution/suspension - clostridium botulinum type c toxoid vaccine-toxoid active 0.0 p; clostridium botulinum type d toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.13 g/l - immunotherapy - bull | cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | male cat - botulism

Israel - engelska - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 300 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Israel - engelska - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 500 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.